ACP Supports Creating National Rx Drug Monitoring Database

Wednesday, December 11, 2013
 
The American College of Physicians supports the development of a national prescription drug monitoring program, which would create a single database that physicians and pharmacies could electronically review before prescribing controlled substances, according to a position paper, CBS News reports. The paper was published in the Annals of Internal Medicine on Monday (Jaslow, CBS News, 12/9).

 

A new national drug data base will extend the failed “War on Drugs”, criminalize millions more, increase patients’ reluctance to use controlled substances, and NOT improve treatment for addiction. US prescriptions are already collected and sold daily by prescription data aggregators like IMS Health, Merck Medco, SureScripts, etc., etc. These businesses all sell the nation’s prescription data to any willing buyers.Meanwhile neither physicians nor patients can get electronic copies of prescription data to improve care.Who should health technology benefit? Patients or corporations?

Why not use patients’ prescription data, already being collected by the hidden data aggregation industry, to improve patient health?

Why not use technology to strengthen the patient-physician relationship and to ensure effective diagnosis and treatment?

For example, here is one way technology could be re-designed to help patients:

Anytime a patient gets a controlled substance prescription, existing systems could automatically search for any prior controlled substance prescriptions the patient received in the last month. If a second or third prescription is found, the physician(s) and patient could be automatically notified and resolve together whether it should be filled or not—and how best to treat the patient’s symptoms

Technology should give patients and doctors they data they need for effective TREATMENT. It’s sad that such a prominent physician group supports giving law enforcement automatic access to every controlled substance prescription in the US. Law enforcement should only be able to access such sensitive patient data AFTER someone has committed a crime or with a judge’s approval.

Why open ALL prescriptions to law enforcement surveillance when the vast majority of patients taking controlled substances are not criminals?

Addiction is NOT a crime, it’s a very treatable medical illness.

deb

 

Your Health Information Isn’t Secure But Don’t Blame EHRs

There’s a lot of talk about the risks of storing health information in electronic medical records (EMRs). But, EMRs aren’t the problem. Those consent forms you sign at the doctor’s office… yeah, you should pay attention to the fine print. You may be giving permission to insurance companies, drug makers, and data aggregators to access your health information, regardless of how or where it’s stored. Sorry to get all sour grapes, but we just want to set the record straight. Here’s what you need to know about who can see your health information, how they can legally use it, and what you can do to protect yourself.

Your Doctor Isn’t the Only Person Who Knows Your Diagnosis

Have you heard of the Medical Information Bureau (MIB)? What about IntelliScript and MedPoint? These organizations, among others, build databases of Americans’ private medical information and sell it to other companies (MIB, a non-profit, only provides the information to its members). It’s perfectly legal. But, ethical? Well, you decide.

Data aggregators track down diagnoses codes, lab data, and prescriptions from databases such as those kept by pharmacy benefit managers. The data is later sold to health and life insurance companies to assess the risk of writing a policy. In other words, they can use it to determine rates, or possibly deny you service. However, we should point out that the MIB uses proprietary codes and only receives this information from member companies. The codes are “brief resumes” that act as “red flags” about a particular medical impairment or risk to a patient’s mortality or morbidity. MIB members aren’t supposed to make underwriting decisions based solely on a code.

Some of these organizations even perform analysis for insurance companies. For example, IntelliScript from Milliman provides insurers with drug profiles of patients. In each patient profile, they assign color codes to a drug – red, yellow, or green – in order to indicate its risk factor. Red means risk. It could be used to spotlight drugs for serious illnesses like cancer or AIDS.